Bioanalytical and Formulation Core
Bioanalytical and Formulation Core
批准号:
8889594
负责人:
Mark A Marzinke
金额:
$43.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AddressAdherenceAlgorithmsApplications GrantsAreaAttributes of ChemicalsBiologicalBiological ProductsClinicalClinical ResearchClinical TrialsCollaborationsCollectionColonColorectalDataData AnalysesData ReportingData Storage and RetrievalDevelopmentDrug FormulationsDrug KineticsElementsEnsureEthicsEvaluationExcipientsFumaratesGelGenerationsGoalsHIVHumanImageImage AnalysisKineticsLaboratoriesLiquid substanceMeasurementMethodsModelingParentsPharmaceutical PreparationsPharmacologic SubstancePharmacy (field)Pharmacy facilityPlasmaPreparationPrincipal InvestigatorProceduresProcessProdrugsProphylactic treatmentProtocols documentationRadiolabeledReportingReproducibilitySamplingSampling StudiesSeriesSiteStatistical AlgorithmStructureTenofovirTenofovir disoproxil fumarateTestingTissuesValidationWorkbaseclinical research siteenema administrationexperiencemicrobicidenoveloperationpre-clinicalproduct developmentprogramsquality assuranceradiotracerrectalrectal microbicidestability testing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The overall goal of the Analytical, Biostatistical and Pharmaceutics Core (Analytical Core C) is to provide
support to the DREAM Program with respect to rectal microbicide enema formulation and physical
characterization for tenofovir (TFV) and TFV prodrugs (TFV disoproxil fumarate [TDF], TFV alafenamide
fumarate [TAF], and CMX157), development and application of quantitative methods for biological sample
analysis, and statistical analysis of study data. The operations of Core C focus around the central idea of
analysis, with regards to pharmaceutical product formulation (pharmaceutics), drug concentration in biological
matrices (analytical), and statistical interpretation of generated data (biostatistical). For bioanalytical studies,
Analytical Core C will focus on the development and validation of liquid chromatographic-tandem mass
spectrometric (LC-MS/MS) methods for the quantification of TFV and TFV prodrugs in plasma, rectal fluid, and
tissue. Biopharmaceutical work conducted in Analytical Core C will focus on the development of
extemporaneous compounding methods and quality assessments for TFV enema products. The Biostatistical
expertise within Analytical Core C will allow the DREAM program to use statistical algorithms to project TFV
and TFV prodrug kinetics in the colon. Thus, each area within Analytical Core C will work in tandem to support
the pre-clinical and clinical projects of the DREAM program. Analytical Core C has significant experience in
the areas of bioanalysis, formulation development, and biostatistical image analysis. Further, Drs. Marzinke
(Analytical Core C Leader), Rohan (Analytical Core C Co-Leader) and Caffo have long-standing collaborations
with Dr. Craig Hendrix, the principal investigator of the DREAM program. Through the provision of
pharmacokinetic data on TDF, TAF, and CMX157, the core will directly support Projects 1, 2 and 3 of this grant
proposal. Formulation based efforts provided through this Core will assist Projects 1, 2, 3, & 4 as well as Core
B.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Improving PrEP protection of transgender women through mechanistic pharmacokinetic understanding
-
批准号:10355444
-
项目类别:
-
资助金额:$56.76万
-
财政年份:2019
-
负责人:Mark A Marzinke
-
依托单位:
Improving PrEP protection of transgender women through mechanistic pharmacokinetic understanding
-
批准号:9891005
-
项目类别:
-
资助金额:$56.76万
-
财政年份:2019
-
负责人:Mark A Marzinke
-
依托单位:
Bioanalytical and Formulation Core
-
批准号:8768694
-
项目类别:
-
资助金额:$44.94万
-
财政年份:2014
-
负责人:Mark A Marzinke
-
依托单位:
Bioanalytical and Formulation Core
-
批准号:9313777
-
项目类别:
-
资助金额:$114.8万
-
财政年份:--
-
负责人:Mark A Marzinke
-
依托单位:
Bioanalytical and Formulation Core
-
批准号:9088360
-
项目类别:
-
资助金额:$70.67万
-
财政年份:--
-
负责人:Mark A Marzinke
-
依托单位:
海外基金